Zhongnan Medical Journal Press

Home Results

A total of 13 result was found. Results that relate to Immune checkpoint

Case report and literature analysis of hypothyroidism induced by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(2):227-232.
10773 times 4379 times

Fei-Long TAN Hong-Ying XIA Zhong-Juan WANG Li DING Li-Na YOU Li ZHOU Jian JIN

Pembrolizumab Immune checkpoint inhibitors Hypothyroidism Adverse drug reaction
Details
A case of Immune-associated myocarditis in a tumor patient with diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2023,32(4):471-475.
9358 times 3650 times

Min CHEN Ming-Wei ZHANG Wei AN Fei YAN

Tumor Diabetes Immune checkpoint inhibitors Myocarditis
Details
A case of immune myositis and peripheral neuropathy induced by immune checkpoint inhibitor

Published on Journal of Mathematical Medicine 2023,36(4):316-320.
9194 times 2009 times

Tian-Zi XU Teng-Fei WANG Yi-Xin LIU Yong-Chang WEI

Immune checkpoint inhibitors Immune myositis Peripheral neuropathy Perihilar cholangiocarcinoma
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):901-908.
10638 times 1736 times

YANG Dan WANG Jinxiu MAO Dahua

Triple-negative breast cancer Immunotherapy Antibody-drug conjugates Clinical trials Immune checkpoint inhibitors Chemotherapy
Details
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma

Published on New Medicine 2024,34(5):593-602.
11423 times 2527 times

JIA Xiaorong ZHANG Gong

Glioblastoma Immunotherapy Immunocyte Immune checkpoint inhibitors
Details
Myocardial infarction induced by penpulimab and anlotinib: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):231-235.
10203 times 1550 times

WANG Chunhui JIANG Mengfei WU Wei ZHOU Yuhong

Immune checkpoint inhibitor Tyrosine kinase inhibitor Myocardial infarction Adverse drug reaction
Details
Clinical efficacy analysis of cross-line immunotherapy in driver gene-negative advanced non-small cell lung cancer patients

Published on New Medicine 2025,35(2):151-161.
12639 times 2170 times

WANG Yuankun LU Jiahao HU Jing XIE Conghua

Cross-line immunotherapy Non-small cell lung cancer Immune checkpoint inhibitors Prognosis Driver gene-negative
Details
Research progress on the immunological characteristics of liposarcoma

Published on Journal of Mathematical Medicine 2025,38(4):297-302.
10277 times 1764 times

HE Xiaoxia ZHAO Huanhuan

Liposarcoma Tumor-infiltrating lymphocyte Immune checkpoint Immunotherapy
Details
A case of tumor hyperprogression caused by treatment of lung squamous cancer with serplulimab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1099-1103.
10353 times 1643 times

YING Yuanyuan MOU Yongxiao ZHU Qiuna ZHENG Song LOU Songgao LOU Jiang

Serplulimab Hyperprogression Immune checkpoint inhibitors Adverse drug reaction
Details
Analysis of immune checkpoint inhibitor induced hypothyroidism based on the U.S. FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(7):1186-1191.
9567 times 1278 times

WANG Huiru YANG Hua REN Yanfei CAO Zhibao LI Xue

Immune checkpoint inhibitors Hypothyroidism FDA Adverse Event Reporting System Drug vigilance
Details
Progress of gut microbiota in tumor immunotherapy

Published on New Medicine 2025,35(9):1099-1107.
12120 times 1401 times

ZHANG Xiaoqing SU Rina LIU Shuai ZHANG Kai HE Jing WANG Yuchao LUAN Wei

Gut microbiota Immune system Immune checkpoint inhibitors Tumour therapy
Details
Retrospective analysis of immune checkpoint inhibitor-induced colitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1390-1398.
4041 times 800 times

SONG Jialin WU Lei WANG Yiting

Immune checkpoint inhibitors Drug-induced colitis Immunotherapy toxicity Risk factors Retrospective analysis
Details
A case of upper gastrointestinal bleeding caused by atezolizumab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1468-1472.
3234 times 700 times

LIU Xinmiao TONG Jingjing

Atezolizumab Upper gastrointestinal bleeding Immune checkpoint inhibitors Adverse drug reactions
Details